Potential Therapeutic Molecules for SARS-CoV-2 Three Years since the Outbreak of COVID-19

Dear Colleagues,

The recent outbreak of a novel coronavirus and its variants responsible for the coronavirus pandemic disease 2019 (COVID-19), which has caused infections with a high mortality rate around the world. Our understanding of COVID-19, including its detection, prevention, and the various approaches for the treatment have been increased daily for the last three years. However, there are still no specific effective pharmacological agents available for the prevention/treatment of SARS-CoV-2 infections. This warrants the search for new effective antiviral therapeutics against coronaviral infections. The present Special Issue of "Molecules" titled ‘Potential Therapeutic Molecules for SARS-CoV-2 Three Years Since the Outbreak of COVID-19’, aims to gather the discovery of the potential drugs of COVID-19.

Dr. Mohammad Ajmal Ali
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.